Chimera Investment Corporation
NYSE:CIMREIT - Mortgage
+$0.12 today
- Market cap
- $541.62M
- Beta
- 1.76
- P/E (TTM)
- 58.1
- EPS (TTM)
- $0.23
- Dividend yield
- 11.65%
Volume 1.98M
Average 0.70M
CIM Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Chimera Investment CorporationNYSE: CIM
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 88.0% from a year ago
Cash & equivalents stood at $476.22M at the end of Q1 FY2026, up 88.0% from a year earlier and up 70.9% from the prior quarter. Over 3 fiscal years it compounded at +1.7% a year.
Context
- Cash & equivalents amounted to 3.0% of total assets at the end of Q1 FY2026, up 1.1 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +88.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 278.58M USD
- Year-over-year change
- +231.7%
- 4-year CAGR
- -7.8%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 278.58M | +231.7% |
| FY2024 | 2024-12-31 | 84M | -62.1% |
| FY2023 | 2023-12-31 | 221.68M | -16.2% |
| FY2022 | 2022-12-31 | 264.6M | -31.4% |
| FY2021 | 2021-12-31 | 385.74M | — |
Cash & Equivalents vs competitors
How CIM compares with its peers on the latest reported figures
- CIM's Mar 2026 cash & equivalents of $476.22M is the 4th highest of the 9 companies compared; the peer median is $437.56M.
- Its year-over-year change of +88.0% is the 3rd highest of 9, against a peer median of +13.3%.
- Cash & equivalents amounts to 3.0% of total assets for CIM, versus a peer median of 1.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $2.18B | +580.8% | +137.3% | 1.5% | |
| Mar 2026 | $760.13M | +91.8% | +52.2% | 6.0% | |
| Mar 2026 | $476.31M | -17.0% | +7.2% | 4.5% | |
| Mar 2026 | $476.22M | +88.0% | +1.7% | 3.0% | |
| Sep 2026 | $468M | +4.0% | -42.2% | 0.4% | |
| Mar 2026 | $407.13M | +31.8% | -3.3% | 2.8% | |
| Mar 2026 | $221.57M | -12.7% | -13.9% | 1.7% | |
| Jun 2026 | $83.68M | -40.7% | -10.2% | 0.4% | |
| Mar 2026 | $52.6M | +22.6% | -31.7% | 0.8% | |
| Peer median (excluding CIM) | $437.56M | +13.3% | -6.7% | 1.6% | |
Competitors are the stored peer set for CIM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 385.74M | 264.6M | 221.68M | 84M | 278.58M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 12.26B | 11.36B | 11.4B | 11.2B | 115.99M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 88.59M | 140.14M | 88.53M | 85.94M | 0 |
| Total Current Assets | 12.74B | 11.76B | 11.71B | 11.37B | 394.57M |
| Property, Plant & Equipment (Net) | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 2.63B | 1.6B | 1.19B | 1.65B | 4.28B |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 39.24M | 34.06M | 30.4M | 102.42M | 11.13B |
| Total Non-current Assets | 2.67B | 1.64B | 1.22B | 1.75B | 15.41B |
| Total Assets | 15.41B | 13.4B | 12.93B | 13.12B | 15.81B |
| Account Payables | 488.99M | 25.9M | 168.25M | 499.81M | 0 |
| Short-term Debt | 4.9B | 3.97B | 2.68B | 3.79B | 6.03B |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 86.15M | 64.55M | 54.55M | 34.27M | 0 |
| Total Current Liabilities | 5.49B | 4.09B | 2.94B | 4.37B | 6.03B |
| Long-term Debt | 6.18B | 6.65B | 7.43B | 6.22B | 7.04B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 165.26M |
| Total Non-current Liabilities | 6.18B | 6.65B | 7.43B | 6.22B | 7.2B |
| Total Liabilities | 11.67B | 10.74B | 10.37B | 10.59B | 13.24B |
| Common Stock | 2.37M | 2.32M | 804K | 809K | 834K |
| Retained Earnings | (1.03B) | (1.88B) | (2B) | (2.02B) | (2B) |
| Accumulated OCI | 405.05M | 229.34M | 185.67M | 159.45M | 146.3M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 3.74B | 2.67B | 2.56B | 2.53B | 2.57B |
| Total Debt | 11.08B | 10.61B | 10.11B | 10.01B | 13.07B |
| Net Debt | 10.69B | 10.35B | 9.89B | 9.93B | 12.79B |
Chimera Investment Corporation
NYSE:CIM
Intrinsic Alpha fair value
Locked
Current Price
$6.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.